UNSPSC 41202064: Toxoplasma gondiiserological reagents

In this classification, Toxoplasma gondii serological reagents are devices used in test to identify specific Toxoplasma gondii antibodies in serum. US FDA regulates Toxoplasma gondii serological reagents under 21 CFR 866.3780 and under FDA product code GMN.

UNSPSC 41202064 Toxoplasma gondiiserological reagents is a Commodity code that does not reflect the actual scope of state and local procurement activity under this classification. The recent opportunities posted under this code involve HIV, Syphilis, Neisseria gonorrhoeae, and Chlamydia trachomatis testing kits, reagents, and related laboratory supplies—not Toxoplasma gondii serology. State and local health departments, county correction and community supervision agencies, and public health programs are the primary issuing bodies, with the Illinois Department of Public Health, City of Austin Public Health, and Collin County appearing most frequently. Work being solicited ranges from manufacturer-specific reagent rentals and analyzer-compatible test supplies to specimen collection and testing services. The Illinois Department of Public Health has posted multiple emergency and change-order notices for Abbott Laboratories HIV/Syphilis reagents and consumables supporting ARCHITECT i1000SR analyzers at the Carbondale Laboratory, while the City of Austin has issued two sequential IFBs for Abbott Determine HIV 1/2 test kits and controls (approximately 375–79 units annually).

Geographic activity concentrates in Illinois and Texas, with secondary activity in Georgia. Representative recent opportunities include the Illinois Department of Public Health change order (Contract 68500013N, due October 13, 2026) increasing annual Hologic NG/NT test volume from 15,000 to 25,000 tests and kit quantities from 15,000 to 30,000 units, raising contract cost by $375,000 to a revised total of $900,000 over five years; Collin County's RFP for offender specimen collection and drug testing services (RFP 2026-327, due July 23, 2026) covering approximately 25,031 annual tests at an estimated $600,000 contract value over two years plus three optional one-year renewals; and the City of Austin's rebid IFB for HIV test kits (IFB 9100 AAM1023REBID, due September 3, 2026) requesting 375 test kits and 79 control kits on as-needed terms. The code shows active state-level procurement but the taxonomy mismatch between the nominal code name and the actual testing categories being bought signals a potential classification issue worth clarifying with issuing agencies.